Try the modernized beta website. Learn more about the modernization effort.
Working… Menu

Evaluation of ADG20 for the Treatment of Mild or Moderate COVID-19 (STAMP)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. Identifier: NCT04805671
Recruitment Status : Recruiting
First Posted : March 18, 2021
Last Update Posted : December 8, 2021
Information provided by (Responsible Party):
Adagio Therapeutics, Inc.

No Study Results Posted on for this Study
Recruitment Status : Recruiting
Estimated Primary Completion Date : January 2022
Estimated Study Completion Date : February 2023